| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | BRISTOL MYERS SQUIBB CO | 198,155,594 | 9.7% | EDGAR |
| SC 13G/A | 2024-01-25 | BlackRock Inc. | BRISTOL MYERS SQUIBB CO | 168,098,227 | 8.3% | EDGAR |
| SC 13G | 2023-12-04 | BRISTOL MYERS SQUIBB CO | Avidity Biosciences, Inc. | 5,075,304 | 6.4% | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | BRISTOL MYERS SQUIBB CO | 202,927,620 | 9.5% | EDGAR |
| SC 13G/A | 2023-02-07 | BlackRock Inc. | BRISTOL MYERS SQUIBB CO | 172,720,377 | 8.1% | EDGAR |
| SC 13G/A | 2022-02-09 | VANGUARD GROUP INC | BRISTOL MYERS SQUIBB CO | 199,834,483 | 9.0% | EDGAR |
| SC 13G/A | 2022-02-01 | BlackRock Inc. | BRISTOL MYERS SQUIBB CO | 169,226,706 | 7.6% | EDGAR |
| SC 13G | 2021-11-19 | BRISTOL MYERS SQUIBB CO | COMPUGEN LTD | 4,757,058 | 5.5% | EDGAR |
| SC 13G | 2021-07-26 | BRISTOL MYERS SQUIBB CO | Celularity Inc | 11,953,274 | 9.9% | EDGAR |
| SC 13D/A | 2021-04-05 | BRISTOL MYERS SQUIBB CO | AGIOS PHARMACEUTICALS, INC. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2021-04-05 | BRISTOL MYERS SQUIBB CO | Jounce Therapeutics, Inc. | 3,456,463 | 7.6% | EDGAR |
| SC 13G/A | 2021-04-05 | BRISTOL MYERS SQUIBB CO | IDEAYA Biosciences, Inc. | 1,633,254 | 5.1% | EDGAR |
| SC 13G/A | 2021-04-05 | BRISTOL MYERS SQUIBB CO | SUTRO BIOPHARMA, INC. | 1,726,197 | 3.8% | EDGAR |
| SC 13G | 2021-04-05 | BRISTOL MYERS SQUIBB CO | Ikena Oncology, Inc. | 2,133,142 | 5.9% | EDGAR |
| SC 13G/A | 2021-02-10 | VANGUARD GROUP INC | BRISTOL MYERS SQUIBB CO | 199,340,458 | 8.8% | EDGAR |
| SC 13G/A | 2021-01-29 | BlackRock Inc. | BRISTOL MYERS SQUIBB CO | 172,464,804 | 7.6% | EDGAR |
| SC 13D/A | 2020-07-16 | BRISTOL MYERS SQUIBB CO | ACCELERON PHARMA INC | 7,008,510 | 12.0% | EDGAR |
| SC 13G/A | 2020-02-12 | VANGUARD GROUP INC | BRISTOL MYERS SQUIBB CO | 194,860,154 | 8.3% | EDGAR |
| SC 13G/A | 2020-02-05 | BlackRock Inc. | BRISTOL MYERS SQUIBB CO | 171,343,446 | 7.3% | EDGAR |
| SC 13G/A | 2020-01-28 | WELLINGTON MANAGEMENT GROUP LLP | BRISTOL MYERS SQUIBB CO | 83,470,877 | 3.6% | EDGAR |